Adenovirus Based Coronavirus Vaccine Being Tested
Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]
U.S. Marines and Navy Prepare to Execute Pandemic Plan As Questions Resurface About Coronavirus Origin
Responding to the coronavirus outbreak in China, where tens of thousands of citizens suspected of being infected with coronavirus (COVID-2019) have been detained and involuntarily taken to quarantine camps,1 on Feb. 1, 2020 an executive order was issued by the U.S. Department of Defense (DoD), including the Joint Chiefs of Staff, directing the U.S. Northern […]
HIV Vaccine Fails Clinical Trial in South Africa
Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]
Fluzone Quadrivalent Influenza Vaccine Approved by FDA for Elderly
The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (BLA) for the Fluzone high-dose quadrivalent influenza vaccine for use by adults 65 years of age and older. Fluzone is manufactured by Sanofi Pasteur, Inc. of France.1 2 The Fluzone high-dose influenza vaccine was approved by the FDA in 2009 as […]
Quest for Universal Flu Vaccine Boosted by $200M NIH Grant to University of Maryland
Story Highlights National Institutes of Health (NIH) has awarded the University of Maryland a contract for more than $200 million to develop a universal influenza vaccine. Currently, the influenza vaccine used around the world is developed every year by drug companies based on the “best guesses” made by public health officials at the World Health […]
NIH and Johnson & Johnson to Begin HIV Vaccine Trials on Humans
Story Highlights NIH, in collaboration with Johnson & Johnson, will begin HIV vaccine efficacy trials on humans in August 2019 in the U.S. Another HIV vaccine candidate, using a live attenuated herpes cytomegalovirus (CMV), is also nearing clinical trials in humans. There are serious safety concerns regarding live attenuated vaccines and numerous cases reported in […]